Join to View Full Profile
4100 John R StGershenson Radiation Oncology CTRDetroit, MI 48201
Phone+1 800-527-6266
Fax+1 313-576-9640
Dr. Vaishampayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nitin Vaishampayan is a radiation oncologist based in Detroit, MI with a notable teaching role at Karmanos Cancer Center. His medical education started at University of Michigan, followed by an internship and residencies at Wayne State University School of Medicine and Detroit Medical Center/Wayne State University respectively. Having specialized in Radiation Oncology, he has made substantial contributions to medical literature, with numerous well-cited publications in recognized journals on topics ranging from Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer, pediatric myeloid sarcoma to the prognostic value of ratio changes in cervical cancer patients.
Education & Training
Detroit Medical Center/Wayne State UniversityResidency, Radiation Oncology, 1992 - 1996
Wayne State University School of MedicineInternship, Transitional Year, 1991 - 1992
University of Michigan Medical SchoolClass of 1991
Certifications & Licensure
MI State Medical License 1996 - 2027
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Understanding the Factors Related to Early Discontinuation of Lutetium-177 Vipivotide Treatment in Men With Metastatic Castration-Resistant Prostate Cancer at a Single...Mannat Bedi, Danishi Bedi, Peter Whatts, Phillip Jenkins, Nitin Vaishampayan
Cureus. 2025-09-01 - 2 citationsAnaphylactic shock during SpaceOAR Vue hydrogel procedure.Lauren Nesi, Paramjot Gogia, Aishwarya Navalpakam, Nitin Vaishampayan, Conrad Maitland
Urology Case Reports. 2024-11-01 - 5 citationsPhase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients.Ulka N Vaishampayan, Lance Heilbrun, Nitin Vaishampayan, Felicity W K Harper, Dongping Shi
International Journal of Radiation Oncology, Biology, Physics. 2024-04-01
Press Mentions
Karmanos Multiple Myeloma Expert Graces Hour Detroit’s 2025 Top Docs Cover, List Includes Over 80 Karmanos PhysiciansOctober 1st, 2025- Are You Ready for Radiation Oncology's Biggest Meeting of the Year?September 9th, 2025
- What Young Males Need to Know About Testicular CancerApril 10th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
